Overview

A Registry To Evaluate Safety And Effectiveness Of Everolimus Drug Eluting Stent For Coronary Revascularization

Status:
Unknown status
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
This is a prospective, multi-center registry to evaluate safety and effectiveness of the Everolimus Drug Eluting Stent for treatment coronary revascularization in Chinese patients with long lesion, small vessel or multi-vessel diseases.
Phase:
Phase 4
Details
Lead Sponsor:
CCRF Consulting Co., Ltd.
Treatments:
Aspirin
Bivalirudin
Clopidogrel
Everolimus
Heparin
Sirolimus